Chieh-Chen Huang

This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Academia Sinica, National Chung Hsing University. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chieh-Chen Huang. Retrieved from https://idiyas.com/inventor/chieh-chen-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 4)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Taipei, TW (2023)
Taichung, TW (2011 - 2024)

Company Filing History:

National Chung Hsing University

patents

Years Active: 2011-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11858965 - Recombinant cellulosome complex and uses thereof (2024-01-02),

2. 11781124 - Recombinant polynucleotide sequence for producing astaxanthin and uses thereof (2023-10-10),

3. 10865397 - Recombinant polynucleotide sequence for producing astaxanthin and uses thereof (2020-12-15),

4. 10087450 - Engineered yeast for production of enzymes (2018-10-02),

5. 9340794 - Method for ordering and introducing multiple genes into a genome (2016-05-17),

6. 8703474 - Flavor compound-producing yeast strains (2014-04-22),

7. 8431371 - Expression system for producing multi-enzyme complexes and uses thereof (2013-04-30),

8. 8354266 - Method for producing extracellular multi-enzyme complexes in host cells (2013-01-15),

9. 8003344 - Microbial hydrogen-producing process and system thereof (2011-08-23),

Title: Chieh-Chen Huang: Innovator in Sarcopenia Treatment

Introduction

Chieh-Chen Huang is an inventor based in Taichung City, Taiwan. He is focused on developing innovative compositions for treating and relieving sarcopenia, a condition characterized by the loss of muscle mass and strength. His work aims to provide effective solutions for individuals suffering from this condition.

Latest Patent Applications

Chieh-Chen Huang has submitted a patent application titled "Compositions for Treating and/or Relieving Sarcopenia and Uses Thereof." This composition includes a microbial component, M1, which has a microbial number ranging from 10 CFU/g to 10 CFU/g. Additionally, the composition features CC212, which is deposited in the Bioresource Collection and Research Center with a deposit number of BCRC911233. The microbial number of CC212 also ranges from 10 CFU/g to 10 CFU/g. The application describes the oral administration of this composition to a subject, where M1 releases exosomes that promote muscle growth, while CC212 releases exosomes that effectively reduce fat mass. Consequently, subjects using this composition could experience an increase in muscle mass and a reduction in fat.

Conclusion

Chieh-Chen Huang is making significant strides in the field of sarcopenia treatment through his innovative compositions. His latest patent application reflects his commitment to addressing this important health issue.

Profile summary based on public USPTO records.